Niaid VRC operational task order
Ended Awarded Last action
- Contract number
- 75N91024F00014
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $39,790,398
Award facts
- Contract value 100% obligated
- $39,790,398.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $2,009,327 | |
| Original award | $37,781,071 |
About this award
This federal contract award, valued at $39,790,398.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract was awarded to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc., to provide operational support for the NIAID Vaccine Research Center (VRC). The contract type is a Delivery Order with a Cost Plus Fixed Fee pricing structure, and the ultimate completion date is August 30, 2025. The award does not have a set-aside designation.
Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor that provides a range of biomedical research and facilities support services to federal agencies, with a focus on the National Institutes of Health (NIH). The company has subcontracted with Brooks Instrument LLC, a manufacturer of flow and pressure instrumentation, and Nuaire Inc., a supplier of laboratory equipment, to support the NIAID VRC contract. Sartorius Stedim North America Inc., a subsidiary of the German company Sartorius Aktiengesellschaft, has also been awarded a subcontract for decommissioning and packing of an AMBR system. These subcontract awards indicate the diverse range of specialized products and services required to support the operational activities of the NIAID VRC.
Quick answers
Who was awarded contract 75N91024F00014?
75N91024F00014 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2024.
How much is contract 75N91024F00014 worth?
The government has obligated $39,790,398 on 75N91024F00014.
Which agency awarded contract 75N91024F00014?
National Cancer Institute (National Institutes of Health) awarded 75N91024F00014, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract 75N91024F00014 an order under another contract?
Yes. 75N91024F00014 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91024F00014 competed?
The extent of competition for 75N91024F00014 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award